| Tag | Content |
|---|
EnhancerAtlas ID | HS091-21138 |
Organism | Homo sapiens |
Tissue/cell | HepG2 |
Coordinate | chr17:73733730-73735750 |
Target genes | | Number: 41 | Name | Ensembl ID |
|
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| ESR1 | MA0112.3 | chr17:73734508-73734525 | AAGGTCACCATGCCCTA | + | 6.2 | | ESR2 | MA0258.2 | chr17:73734509-73734524 | AGGTCACCATGCCCT | + | 7.7 | | RREB1 | MA0073.1 | chr17:73734293-73734313 | ACCCACACCAACCCCATCCA | + | 7.25 | | SREBF2 | MA0596.1 | chr17:73734484-73734494 | ATCACCCCAT | - | 6.02 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_53680 | chr17:73733599-73735066 | Spleen |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 3 | Chromosome | Start | End |
| chr17 | 73734249 | 73734591 | | chr17 | 73734309 | 73734806 | | chr17 | 73734014 | 73734237 |
|
| | Number: 3 | ID | Chromosome | Start | End |
| GH17I075738 | chr17 | 73733186 | 73733807 | | GH17I075737 | chr17 | 73733882 | 73735280 | | GH17I075739 | chr17 | 73735563 | 73737054 |
|
Enhancer Sequence | CACCCAGGGT GCCTCCCAAG GCCCCACATC CCAGGGTCCC CACCCCAACA GGGCCCCCAC 60
CCTCCACCAG GGTCCCCAGT CCCCGCCTGA GTTCTCATCT CCCCAGGGTC CCCAACCCCT 120
TCCTGGGTCC CCACCTCCCC AGGGTCCCCA TCCCAACAGG GTCCCCATCC TCCACCACGG 180
TCCCCACCTC CCCAGTGTCC TCAACCCCCT CCTGGGTCCC CACCTCACCA GGGTCCCCTC 240
TCTGACAGGG TCTCCACCCT CCATCAGGGT CCTCCTCAGG GTCCCCAACC CCCACCAGGG 300
TCCCCAGCCT CTCCACCCAC CATCCCCACT CCTGCAGCTT TCTAGCCAGA GGCTTCAGCC 360
CGTAGAGTCC AGCTGTCTGG ATTCTGGTCC CAGCTCTGTG ACCTTGGGCA AATTACTTAA 420
TCTCTCCATG CCTCAGTTCC CTCATCTGTA AAATGAAGAT CATAGAATTG ACCTCAGAAA 480
GTGGAGCTGA AGCTTAAATT AGTGAAGTTC AGAAGGGACT GACCCATAGC ATGCACCATC 540
GCCCCCACCC CCACCTTGGC AAGACCCACA CCAACCCCAT CCAGCTTCCG GAGTGACAGT 600
AATGATGATG ACACCCATGA GCTCTTAGCC CGAGTCATCC TGGAGCCCCA GCCCCCAGCT 660
CAGCCCTTGC CAGCATCCGT TCTCTGCTTA GCTCAGTGTT CCTCTTTGTG CTGTCGCCAC 720
AGCATGTCCA CGTGACTCCA TTTCCCCGCC CCCCATCACC CCATGAGGTC AGTGGGGCAA 780
GGTCACCATG CCCTATGACA GATGGAGAAA TTGGGGCTGA GAGGCAGGTG ATAAATGCAC 840
AGTCCTCAGA AGGGGCTGAG GCAAGCTGAG CCCACATCTT CCCCAGCTCT AGTGCCCGCC 900
CAGGACCCCC ACTCCATCAG CCATCAGTGG CCAGATCCCT GAGAGCACCT GCTCTGGGGT 960
CAGCCACGTG CAAAAGGCCT GGGAGCCACA ACAGGGAAGA AAGGGCCCTG CCCGCCCGCA 1020
GCTGGCGGTC ACTGGGGAGA ACAGACAAGA GAAAGCGTGG AGGATGGCAT AGCTCAGAGT 1080
AGGGATTGTA GGCGGCAGAC CACACTCCGT AGTAACCCCC AGTGTTGTGG GATATTAATG 1140
TGCATTACAT AGGCAAGGAG TTATGTGATC AAATAGGTTT GAGCTAGGCA CGGCTGCGCG 1200
TGCCTGTAGT CCCAGCTACT CAGAAAGCTG AGGCAGGAGG ATCACGAGTC TGGGAGTTTG 1260
AGGCTACAGT GAGCTATGAT TATGCCACTG CACTCCAGCC TGGGTGACAG AGTGAGACTC 1320
AAAAAGAAAA AAAAAAAGAA GGTTTAAGAA ACAAGTTTCT TAAATTTAAG TTACAGTGGC 1380
TCACACTTGT AACCCCAGCA CTTTGGGAGG CCAAGGCGGG TGGATCACTT GAGGTCAGGA 1440
GTTGGAGACA AGCCCGGCCA ATATGGTGAC ACCCCATCTC TACTAGAAAT ACAAAATTAG 1500
CTGGGCATGG AGGTGGATGC CTATAATCCC AGTTACTAGG GGGGCTGAGG CAGGAGAATT 1560
GCTTGAACCT GGGAGGTAGA GGTTGCAGTG AGCCGCGATC GTGCCACTGC ATTCCAGCCT 1620
GGGCAACAGA GCGAGACCCT GTCTCAAAAA AAAAAAAAAG AAAAGAAACA AGTTTCTTCT 1680
CTGCAGGACT TCTCAGAGGC TTTGATAAAG TCCTGTGCCT AACCTGCAAG AGGGGCATGG 1740
GGAATGAATT CAGTGCTTCC CAAGTGAACC TGACCACAGA ACCTTTACAG AGCACCCGGC 1800
AGGATGAGAG TTCCACGGCG CAAACTTTGG GAACCCTCTG CCCCCATCCC CCTCTATGCC 1860
CTTGTGTGCC ATGCTTACAC CCTGCTACCA CCTGGATATT CTGGTGTCTG GGGAGGCACT 1920
GTCACCCCTC TTGACCATTG GCATGGGGCG GGGTGGCTGG AAGGGCTTAC CTGGGCCAGG 1980
GCAGCTGTCT CAGGCCTCAC CCTCACCCAC CTTGTCTCCT 2020
|
